ProtocoleV4: Comparative Study of the Performance of Drug Anamneses in an Emergency Department
Sponsor
Grand Hôpital de Charleroi (Other)
Overall Status
Recruiting
CT.gov ID
NCT05951881
Collaborator
(none)
50
1
4.9
10.1
Study Details
Study Description
Brief Summary
After the first medical history by the nurse and the emergency physician, the pharmacist and the pharmacy assistant take a detailed history of the patient's medications separately.
After checking with the patient's reference pharmacy, the pharmacist and pharmacy assistant compare their results.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparative Study Between a Pharmacy Technician and a Pharmacist in the Performance of Medication Anamneses in Emergency Departments: a Skills Validation Study
Actual Study Start Date
:
Feb 15, 2023
Anticipated Primary Completion Date
:
Jul 15, 2023
Anticipated Study Completion Date
:
Jul 15, 2023
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Urgent care unit patients with medication All patients admitted to the emergency department who agree to describe their medication |
Other: Emergency Care Unit - medicines
The same group of patients admitted to the emergency room will respond separately to a pharmacist and a pharmacy assistant about their daily medication.
The two medical records will be compared in order to evaluate the work of the pharmacy assistant on the basis of 3 sources :
the Electronic Medical Record
the patient's medication history
the reference pharmacy
|
Outcome Measures
Primary Outcome Measures
- Percentage of identical medication anamneses between pharmacist and pharmacy assistant [immediately after admission to the emergency department]
A pharmacist and a pharmacy assistant will compare the medication history of all patients who meet the eligibility criteria
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Admission to the emergency care unit
-
Over 18 years old
-
Giving consent to participate
Exclusion Criteria:
-
Patients who do not take medication daily
-
Unconscious patients
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | GHdC | Charleroi | Hainaut | Belgium | 6060 |
Sponsors and Collaborators
- Grand Hôpital de Charleroi
Investigators
- Principal Investigator: Laurence Rosart, Pharmacist, Grand Hôpital de Charleroi
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Grand Hôpital de Charleroi
ClinicalTrials.gov Identifier:
NCT05951881
Other Study ID Numbers:
- Pharmacie - Protocole V4
First Posted:
Jul 19, 2023
Last Update Posted:
Jul 19, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: